Apollo Hospitals Enterprise Ltd.
Snapshot View

View in App

Prices View details >>

4234.95 -33.15 ▼-0.8%

02 February 2023, 04:01:00 PM
Volume: 7,848

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.apollohospitals.com
Market Cap 60,864.05 Cr.
Enterprise Value(EV) 62,421.16 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 58.39 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 72.52 Trailing Twelve Months Ending 2022-09
Industry PE 46.37 Trailing Twelve Months Ending 2022-09
Book Value / Share 416.25 Trailing Twelve Months Ending 2022-09
Price to Book Value 10.17 Calculated using Price: 4,234.95
Dividend Yield 0.28 Period Ending 2022-03
No. of Shares Subscribed 14.38 Cr. 143,784,657 Shares
FaceValue 5
Company Profile
The company has emerged as Asia's foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models. The Group also has Telemedicine facilities across several countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation. In addition, ‘ASK Apollo' - an online consultation portal and Apollo Home Health provide the care continuum.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.78%
1 Week
+0.23%
1 Month
-4.86%
3 Month
-3.36%
6 Month
-2.08%
1 Year
-9.20%
2 Year
+56.48%
5 Year
+267.94%
10 Year
+422.35%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.66 10.59 6.41 2.68 1.81 6.07 13.08 3.44 21.60
Return on Capital Employed (%) 12.71 12.09 8.57 6.94 7.12 10.24 17.13 9.32 24.92
Return on Assets (%) 6.00 5.51 3.01 1.10 0.65 2.05 3.90 1.10 8.18

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2,977 3,171 3,331 3,313 3,252 3,334 3,339 4,603 5,623 5,993
Non Curr. Liab. 1,557 2,138 2,701 4,399 4,423 4,613 6,483 5,590 6,241 4,708
Curr. Liab. 797 1,076 1,250 963 1,567 1,955 2,337 2,038 2,383 2,963
Minority Int. 19 73 78 125 132 136 131 200 254 300
Equity & Liab. 5,350 6,459 7,360 8,800 9,374 10,037 12,290 12,431 14,502 13,963
Non Curr. Assets 3,849 4,520 5,385 6,671 7,154 7,756 9,643 8,789 10,381 9,610
Curr. Assets 1,501 1,939 1,975 2,129 2,220 2,282 2,647 3,642 4,122 4,353
Misc. Exp. not W/O
Total Assets 5,350 6,459 7,360 8,800 9,374 10,037 12,290 12,431 14,502 13,963

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 4,384 5,178 6,215 7,256 8,243 9,617 11,247 10,560 14,663 15,232
Other Income 21 37 53 44 34 32 33 49 78 87
Total Income 4,406 5,215 6,267 7,300 8,277 9,650 11,280 10,609 14,741 15,319
Total Expenditure -3,712 -4,444 -5,534 -6,549 -7,452 -8,555 -9,666 -9,427 -12,478 -13,126
PBIDT 694 771 733 751 825 1,095 1,614 1,182 2,263 2,193
Interest -119 -118 -180 -257 -295 -327 -533 -449 -379 -374
Depreciation -168 -212 -264 -314 -359 -396 -620 -573 -601 -618
Taxation -102 -130 -97 -91 -112 -173 -225 -85 -477 -308
Exceptional Items 13 16 198 61 294
PAT 305 325 208 89 59 199 435 136 1,101 893
Minority Interest 1 5 1 90 58 36 23 14 -53 -37
Share Associate 10 9 27 42 0 1 -3 1 7 -16
Other Related Items -11
Consolidated Net Profit 317 340 226 221 117 236 455 150 1,056 840
Adjusted EPS 23 24 16 16 8 17 33 10 73 58

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 443 373 470 597 623 537 905 1,293 1,265 1,628
Cash Fr. Inv. -733 -356 -759 -888 -1,152 -405 -711 -289 -863 -778
Cash Fr. Finan. 373 -63 392 330 477 -109 -215 -910 -340 -793
Net Change 83 -46 103 39 -52 24 -20 95 61 57
Cash & Cash Eqvt 320 274 377 379 283 306 286 381 425 583

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 30.82 29.82 29.82 29.82 29.33 29.33 29.33 29.33 29.33
Public 69.08 70.09 70.12 70.12 70.61 70.61 70.67 70.67 70.67
Depository Receipts 0.10 0.09 0.06 0.06 0.06 0.06 0.00 0.00 0.00
Promoter Holding Pledge (%) 30.14 27.94 29.95 22.08 22.32 16.37 16.37 16.37 16.37

Announcements View Details >>

Tue, 31 Jan 2023
Board Meeting Intimation for Notice Of The Board Meeting
APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve As per annexure enclosed
Tue, 31 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations 2015 (Regulations) regarding loss of share certificate.This is to inform you that the Company has received intimation from shareholder on January 31 2023 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations the details of the said share certificates are as given below:Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos.764 Atul Khanna 4794 350764 3775287 to 3780080This is for your information.
Fri, 27 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations 2015 (Regulations) regarding loss of share certificate.This is to inform you that the Company has received intimation from shareholder on January 27 2023 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations the details of the said share certificates are as given below:Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos.1673 Datt S C 1000 351674 4231351 to 4232350This is for your information

Technical Scans View Details >>

Thu, 02 Feb 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
Closing Near 200 SMA Closing Near 200 SMA

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Abbott India Ltd. 43,527.39 20,505.50 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Abbott India Ltd. Standalone 2022-09 49.36 20,505.50 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Abbott India Ltd. Standalone 2022-09 16.04 20,505.50 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,505.50 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,505.50 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,505.50 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,505.50 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,505.50 -0.9%

FAQ's On Apollo Hospitals Enterprise Ltd.

What is Apollo Hospital Ent. share price?
Can I buy Apollo Hospital Ent. shares now?
What is the Dividend Yield of Apollo Hospital Ent.?
What is the Market Cap of Apollo Hospital Ent.?
What are the key metrics to analyse Apollo Hospital Ent.?
What is the 52 Week High and Low of Apollo Hospital Ent.?
What is the trend of Apollo Hospital Ent. share price?